Investing in Health: The Future of Wellness and Wealth

Summary This episode covers the latest developments in markets, biotech innovations like GLP-1 generics, SpaceX IPO, and the impact of AI on society. It offers insights into investing, healthcare, and technological advancements shaping the future. Chapters 00:00 Market and SpaceX News Overview 01:11 Healthcare Updates: GLP-1 and Infectious Diseases 02:20 Copper Peptides and Beauty Trends 03:04 Charity Event: Rethink Breast Cancer 05:02 Dog Emergency and GLP-1 Generics in Canada 06:26 Canada's First Generic GLP-1 Drugs 08:54 Pharmaceutical Industry and Sales Reps 11:00 Weight Loss Drugs and Body Image 14:27 Eating Disorders and Drug Safety 17:48 Canadian Economy and Consumer Spending 20:29 Retail Trends and Consumer Behavior 22:30 Investing in Retail and Luxury Brands 26:06 Market Trends: US and Canadian Economies 28:00 Interest Rates, Inflation, and Market Outlook 29:17 Starting Investment Early: Pay Yourself First 33:16 Retta Truetide Trial: Weight Loss Breakthrough 36:32 Safety and Efficacy of New Weight Loss Drugs 43:32 SpaceX IPO: Market Potential and Elon Musk 45:37 SpaceX's Satellite and Space Infrastructure 49:21 AI Impact on Society and Companies 52:23 AI Failures and Challenges in Social Media 55:24 Nvidia's AI Chip Success and Market Growth Host descriptions: Catherine Murray, a business newscaster and former Wall Street professional at Goldman, William Blair and Deutsche bank. Dr. Melissa Hershberg, a medical practitioner with a specialized interest in preventive health, weight loss and aesthetic medicine. Disclaimer: for entertainment purposes only, please do your own research, your own homework and consult with a financial advisor for investment discussions. In addition to consulting with your Family Doctor, Physician, GP or other health care providers before making any health and beauty decisions. If you would like to join our email list, please reach out to [email protected] and let us know.